French MedTech Firm RDS Secures €14M for Wearable Patient Monitor
French medical technology firm RDS has secured €14m in a Series A funding round. The investment will support the commercialisation of its MultiSense solution, a wearable patch for remote patient monitoring.
RDS' MultiSense comprises a wearable patch that tracks six key physiological indicators. It's linked to a cloud-based platform and supported by services for continuous remote monitoring. The technology has been used in 15 hospitals across France, Belgium, and Germany, though not yet on a commercial basis.
The funding round was led by SPI Fund, managed by Bpifrance on behalf of the French state. French venture capital firm Critical Path Ventures and others also participated. RDS aims to use the funds to accelerate development and expand into European markets. It plans to scale up production and refurbish capacities, with a target US launch in 2028. The global market for vital signs monitoring is forecast to reach $15bn this year and grow by an average of 15% annually until 2030.
RDS' successful Series A funding round will enable it to scale and commercialise its MultiSense solution. With a growing global market and plans for expansion, the company is well-positioned to make an impact in remote patient monitoring.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Trump Signs Law Defunding Planned Parenthood, Threatening Healthcare Access for Millions
- Historian Ute Frevert Explores Germans' Emotional Bond With Constitutions
- Milei's Ideological Approach Reshapes Argentina's Foreign Policy
